Study Stopped
funding issues
Echocardiographic Assessment of Cardiovascular Changes in Long Term Space Flight
1 other identifier
observational
1
1 country
1
Brief Summary
The National Space Biomedical Research Institute is interested in learning more about heart function in space. One potential problem with long duration, manned space flight is muscle loss- including loss of heart muscle. One goal of our research is to help identify why this muscle loss occurs. We are interested in patients undergoing aortic valve surgery because this procedure is performed to correct a problem with the valve that may also change heart function. This change in heart function may provide information that is useful in understanding and potentially preventing the loss of cardiac muscle in space. Three patient groups will be studied, patients having surgery for aortic regurgitation, aortic stenosis, and coronary bypass. We are planing to perform this study on 30 patients, 10 in each group. The aim of this study is to continue our ongoing study of the magnitude and predictors of the changes in size of the left ventricle following acute volume and pressure unloading as a ground-based analog for manned space flight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2003
CompletedFirst Submitted
Initial submission to the registry
December 27, 2007
CompletedFirst Posted
Study publicly available on registry
January 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedJanuary 12, 2017
January 1, 2008
4.7 years
December 27, 2007
January 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic 2D and 3D echocardiography
6-12 months
Secondary Outcomes (1)
Endogenous gene expression
1 week
Eligibility Criteria
Patients coming to the Cleveland Clinic with aortic valve insufficiency or aortic valve stenosis, undering going repair or replacement, or patient undergoing coronary bypass surgery.
You may qualify if:
- \> 18 years of age
- Isolated severe aortic stenosis
- Preserved left ventricular function
- CABG patients will have normal LV function and mass
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Cleveland Cliniclead
- National Space Biomedical Research Institutecollaborator
Study Sites (1)
Cleveland Clinic
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jim Thomas, MD
The Cleveland Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 27, 2007
First Posted
January 22, 2008
Study Start
October 1, 2003
Primary Completion
June 1, 2008
Study Completion
July 1, 2008
Last Updated
January 12, 2017
Record last verified: 2008-01
Data Sharing
- IPD Sharing
- Will not share